Today: 29 June 2026
P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus
9 January 2026
1 min read

P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus

New York, January 8, 2026, 21:32 EST — Market closed

Procter & Gamble shares rose 2.5% on Thursday to $141.53, after trading between $137.81 and $141.78. Texas Attorney General Ken Paxton said the company agreed to change marketing and packaging for Crest children’s toothpaste to better show the recommended amount.

The agreement matters because it draws a major consumer brand into a fast-moving debate over kids’ products and advertising claims. For investors, it highlights how legal and regulatory friction can surface quickly, even for “defensive” consumer staples names often bought for steady demand.

The calendar timing is awkward. With earnings season about to pull big U.S. companies back onto the tape, traders are scanning for anything that could become headline risk or a margin story, especially in household goods where pricing power and volumes are closely watched.

Paxton said the roll-out began on Jan. 1 and that P&G must remain in compliance for five years. P&G said it was “fully committed to delivering safe, reliable products” and was voluntarily agreeing to update artwork to reflect recommended dosing levels for children, Reuters reported. Reuters

On Wall Street, Piper Sandler assumed coverage with a Neutral rating and a $150 price target, saying the U.S. consumer “remains stretched” and that upside catalysts were not clear without better category momentum. TD Cowen analyst Robert Moskow kept a Buy rating but cut his price target to $150 from $168, saying 2026 would be a “challenging” year for big consumer staples with muted pricing. TipRanks+1

Macro could still drive most of the action into Friday. The U.S. Employment Situation report for December is due at 8:30 a.m. ET and may shift rate-cut bets and tilt sentiment toward defensive stocks; a Chicago Fed estimate put the jobless rate at 4.6%, while the official figure is expected to come in slightly lower, Reuters reported.

But the toothpaste issue may not fade in a day. Label changes and marketing tweaks can be manageable, yet a broader wave of scrutiny, copycat actions, or litigation would be harder to bracket, and any stumble in volumes would leave less room for error if pricing cools.

Investors will next turn to Friday’s jobs data, then to P&G’s fiscal second-quarter results and conference call on Jan. 22 at 8:30 a.m. ET.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Singular Health Group Applies for Quotation of Additional ASX Shares
    June 28, 2026, 8:02 PM EDT. Singular Health Group Ltd has applied for the quotation of 2,571,222 new ordinary fully paid shares on the Australian Securities Exchange (ASX). This move aims to expand the company's market presence and increase liquidity. The application signifies the firm's intent to raise capital or satisfy existing commitments through share issuance. Investors will monitor the impact on share supply and potential dilution. The announcement reflects Singular Health's ongoing efforts to support its growth and operational strategies.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Previous Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop